الوطن
الوطن
Ready to play
Ready to play
The study found that daily intake of vitamin C enhances the chances of survival for patients with pre-cancerous blood disorders or low-risk myeloproliferative neoplasms. The supplements were associated with improved vitamin levels and a reduction in adverse health events. An improvement in survival was observed during nearly three years of follow-up, although the study did not establish the vitamin's ability to definitively halt disease progression. These results require confirmation through phase three trials before being considered as a treatment option, and they suggest that vitamin C might play a supportive role in improving outcomes for certain categories of patients with blood disorders linked to an increased risk of leukemia.
Notice: This Is an AI-Generated Summary
Comments (0)